← k velkým investorům
Vivo Capital, LLC
institucionální investor · portfolio $1.10 mld. · 47 pozic · zpráva k 30.06.2026
Akciové pozice zpráva za 30.06.2026, podána 14.08.2026; změna — oproti 31.03.2026 · 53
| Společnost | Akcie | Hodnota | % portfolia | Změna za čtvrtletí |
|---|---|---|---|---|
| Trevi Therapeutics Inc US:TRVI | 5 094 668 | $95.0 mil. | 8.68% | — |
| Praxis Precision Medicines I… US:PRAX | 271 116 | $90.8 mil. | 8.29% | −67 779 |
| Erasca Inc US:ERAS | 4 127 412 | $75.6 mil. | 6.90% | −8 024 068 |
| ArriVent BioPharma, Inc. US:AVBP | 1 682 097 | $58.4 mil. | 5.34% | +796 181 |
| ABIVAX US:ABVX | 414 899 | $55.3 mil. | 5.05% | +175 360 |
| Tango Therapeutics, Inc. US:TNGX | 1 379 769 | $43.1 mil. | 3.94% | −775 011 |
| Corvus Pharmaceuticals Inc US:CRVS | 2 805 816 | $41.9 mil. | 3.83% | — |
| Bright Minds Biosciences Inc US:DRUG | 557 172 | $39.1 mil. | 3.57% | — |
| Sinovac Biotech Ltd. CUSIP P8696W104 | 5 903 000 | $38.2 mil. | 3.49% | — |
| Tenax Therapeutics Inc US:TENX | 2 500 000 | $36.4 mil. | 3.32% | +2 291 667 |
| Aclaris Therapeutics Inc US:ACRS | 6 694 637 | $35.4 mil. | 3.23% | +27 971 |
| Dyne Therapeutics Inc US:DYN | 1 557 466 | $34.6 mil. | 3.16% | — |
| Dianthus Therapeutics Inc. US:DNTH | 353 998 | $34.5 mil. | 3.15% | — |
| Alto Neuroscience, Inc. US:ANRO | 1 208 858 | $31.9 mil. | 2.91% | +173 307 |
| DBV Technologies US:DBVT | 1 844 758 | $30.3 mil. | 2.76% | −822 811 |
| SAB Biotherapeutics Inc US:SABS | 7 299 909 | $28.5 mil. | 2.60% | −4 120 091 |
| MoonLake Immunotherapeutics US:MLTX | 1 400 000 | $27.3 mil. | 2.49% | +400 000 |
| LB PHARMACEUTICALS INC US:LBRX | 800 000 | $26.0 mil. | 2.37% | — |
| Minerva Neurosciences Inc US:NERV | 4 322 747 | $24.0 mil. | 2.19% | — |
| Design Therapeutics Inc US:DSGN | 1 612 903 | $23.3 mil. | 2.13% | — |
| Oric Pharmaceuticals, Inc. US:ORIC | 1 848 786 | $20.0 mil. | 1.83% | — |
| CAMP4 Therapeutics Corporati… US:CAMP | 4 246 568 | $18.6 mil. | 1.69% | — |
| Faeth Therapeutics, Inc. US:FTH | 722 020 | $18.1 mil. | 1.65% | — |
| Achieve Life Sciences Inc US:ACHV | 2 751 032 | $18.0 mil. | 1.64% | nová |
| Compass Therapeutics, Inc. US:CMPX | 7 757 060 | $17.0 mil. | 1.55% | −1 788 406 |
| AN2 Therapeutics Inc US:ANTX | 3 153 640 | $15.3 mil. | 1.39% | — |
| Editas Medicine Inc US:EDIT | 3 555 250 | $11.5 mil. | 1.05% | nová |
| Geron Corporation US:GERN | 8 671 797 | $11.1 mil. | 1.01% | — |
| Odyssey Therapeutics, Inc. US:ODTX | 575 000 | $10.8 mil. | 0.98% | nová |
| Eupraxia Pharmaceuticals Inc… US:EPRX | 1 350 000 | $8.92 mil. | 0.81% | — |
Ve společnostech z naší databáze 24
| Společnost | Podíl | Akcie | Datum zprávy |
|---|---|---|---|
| InMed Pharmaceuticals Inc | 14.53% | 798 377 | 2026-06-30 |
| Minerva Neurosciences Inc | 9.05% | 4 322 747 | 2026-06-30 |
| AN2 Therapeutics Inc | 8.36% | 3 153 640 | 2026-06-30 |
| SAB Biotherapeutics Inc | 8.02% | 7 299 909 | 2026-06-30 |
| CAMP4 Therapeutics Corporati… | 6.77% | 4 246 568 | 2026-06-30 |
| Bright Minds Biosciences Inc | 5.73% | 557 172 | 2026-06-30 |
| Tenax Therapeutics Inc | 5.49% | 2 500 000 | 2026-06-30 |
| Aclaris Therapeutics Inc | 4.79% | 6 694 637 | 2026-06-30 |
| OnKure Therapeutics, Inc. | 4.77% | 1 927 710 | 2026-06-30 |
| Instil Bio Inc. | 4.32% | 292 743 | 2026-06-30 |
| Sera Prognostics Inc | 4.29% | 1 650 440 | 2026-06-30 |
| Satellos Bioscience Inc. | 3.84% | 813 666 | 2026-06-30 |
| Bolt Biotherapeutics | 3.76% | 72 414 | 2026-06-30 |
| Trevi Therapeutics Inc | 3.58% | 5 094 668 | 2026-06-30 |
| PepGen Ltd | 3.36% | 2 325 000 | 2026-06-30 |
| Corvus Pharmaceuticals Inc | 3.34% | 2 805 816 | 2026-06-30 |
| Alto Neuroscience, Inc. | 3.08% | 1 208 858 | 2026-06-30 |
| DBV Technologies | 2.93% | 1 844 758 | 2026-06-30 |
| Faeth Therapeutics, Inc. | 2.79% | 722 020 | 2026-06-30 |
| Design Therapeutics Inc | 2.58% | 1 612 903 | 2026-06-30 |
| Alx Oncology Holdings | 2.3% | 3 184 713 | 2026-06-30 |
| Eupraxia Pharmaceuticals Inc… | 2.08% | 1 350 000 | 2026-06-30 |
| Unicycive Therapeutics Inc | 1.97% | 550 000 | 2026-06-30 |
| Pasithea Therapeutics Corp | 1.39% | 465 471 | 2026-06-30 |
reklama
